Sutimlimab ( designated) this experimental agent is an targeted antibody with a identification code of 2049079-64-1 . It works by specifically blocking C5 , a component belonging to the complement https://bookmark-template.com/story28733624/sutimlimab-a-deep-investigation-into-this-substance-antibody